EE34 Cost-Effectiveness Analysis of Aztreonam-Avibactam (ATM-AVI) Versus Meropenem for the Treatment of Serious Infections Due to Gram-Negative Bacteria for Which There Are Limited Treatment Options (LTO) in Italy
Abstract
Authors
X. Bao F. Woodcock R. Di Virgilio M. Kantecki J. Chow M. Gheorghe